Onset and duration of action of topical antihistamine: A study of histamine skin test response

International Journal of Dermatology

Volumn 47, Issue 8, 2008, Pages 861-863

  Suswardana, J I ^a   Danarti, Retno ^b   Waskito, Fajar ^b   Indrastuti, Niken ^b  

^a Gadjah Mada University ^*  (Indonesia)

^b GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BIOCREAM; DOXEPIN; HISTAMINE; HOLLISTER STIER; PLACEBO; SAGALON;

ADULT; ALLERGIC REACTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SINGLE DRUG DOSE; SKIN TEST;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALLERGENS; CROSS-OVER STUDIES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; DOXEPIN; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROBABILITY; PRURITUS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SKIN TESTS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 48249107171     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03639.x     Document Type: Article

References (13)

1. Lachapelle JM, Maibach HI. The Methodology of prick testing and its variants. In: Lachapelle JM, Maibach HI eds. Patch Testing and Prick Testing: A Practical Guide. Berlin: Springer Verlag, 2003: 149-161.
2. Purohit A, Melac M, Pauli G, et al. Twenty-four-hour activity and consistency of activity of levocetirizine and desloratadine in the skin. Br J Clin Pharmacol 2003; 56: 388-394.
3. Greaves MW. Antihistamines. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy. Philadelphia: W.B. Saunders, 2001: 360-374.
4. Breneman DL. Doxepin cream relieves eczema-associated pruritus within 15 min and is not accompanied by a risk of rebound upon discontinuation. J Dermatol Treat 1997; 8: 161-168.
5. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol 1995; 131: 1403-1408.
6. Greiding L, Moreno P. Doxepin incorporated into a dermatologic cream. An assessment of both doxepin antipruritic action and doxepin action as an inhibitor of papules, in allergen and histamine-caused pruritus. Allergol Immunopathol (Madrid) 1999; 27: 265-270.
7. European Academy of Allergology and Clinical Immunology. Position Paper: Allergen standardization and skin tests. Allergy 1993; 48 (Suppl. 14): 48-82.
8. Rosmelia, Suswardana, Rusfianti M, Waskito F. Variability of modified 26-G needle with 1 mm depth stopper in histamine skin testing. MDVI 2005; 32 (Suppl.): S14-S18.
9. Karaz SS, Moeckli JK, Davis W, et al. Effect of topical doxepin cream on skin testing. J Allergy Clin Immunol 1995; 96: 997-998.
10. GenDerm. Zonalon Cream (Doxepin Hydrochloride Cream) 5%: A Clinical Review. Lincoln, Illinois: GenDerm Corporation, 1994.
11. Bordignon V, Burastero SE. Age, gender and reactivity to allergens independently influence skin reactivity to histamine. J Investig Allergol Clin Immunol 2006; 16: 129-135.
12. Kidon Mi See Y, Bun CY, Goh A, et al. Bimodal skin reactivity to histamine in atopic children in Singapore: Influence of specific sensitization. Pediatr Allergy Immunol 2004; 14: 545-550.
13. Skassa-Brochek W, Manderscheid JC, Michel FB, et al. Skin test reactivity to histamine from infancy to old age. J Allergy Clin Immunol 1987; 80: 711-716.